This week one of my sources sent me a recent newsletter from linkurl:Allerca,;http://www.allerca.com/indexold.html a "lifestyle pets" company now headquartered in Delaware that claims to have developed hypoallergenic cats. I was interested to read a rant by the company's founder, Simon Brodie, about the "gonzo journalists" who "trumpeted absolute falsehoods and downright lies" regarding the company. I imagine Brodie might be referring to yours truly. Not because I lied in my linkurl:investigati

Lead author found guilty of misconduct in embryonic cell lineage paper called into question over a year ago

The National Science Foundation released two reports to the public this week that examine a puzzling trend: Why, during times of increasing investment in science, is the share of US publications dropping? As I linkurl:reported;http://www.the-scientist.com/news/display/36407 in November of last year, US publication numbers plateaued from 1992 to 2002, and the global percentage of publications coming out of the US dropped from 38% in 1973 to 30% in 2003. Meanwhile, the report shows US academic R&D

Salk researcher developed plaque assay for polio virus

What does society get for the billions it spends on science?

Credit: omeallyphoto.com" /> Credit: omeallyphoto.com Reuben Shaw wanted nothing more than to study tumor suppressor genes, but his results took him on another path. "As fate has it," he sighs in mock defeat, "diabetes will be a part of my research from here on out." In 1993 Shaw joined Tyler Jacks' laboratory at the Massachusetts Institute of Technology as a graduate student. Jacks' lab studied a number of tumor suppressors, including p53 and retinoblas

Group claims the agency violates free speech, and it's made a movie to explain why. Is Congress listening?

Web sites attract beautiful people who use "natural selection" to eliminate the imperfect

How pharmacogenomics might help addiction treatment Naltrexone Molecule 20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments? By Kerry Grens Related Articles 1 In 2003 David Oslin and Charles O'Brien at the University of Pennsylvania's Center for Addiction Treatment and their colleagues reported an association between this SNP and how well patients responded to naltrexo

The brain on drugs Drugs elevate CREB activity in the nucleus accumbens by activating cyclic AMP pathway, causing protein kinase A to translocate to the nucleus and phosphorylate CREB. Target genes involved in addiction include dynorphin, corticotropin releasing hormone (CRH or CRF ), brain-derived neurotrophic factor (BDNF), tyrosine hydroxylase (TH), glutamate receptor subunit GluR1.By Kerry Grens ARTICLE EXTRAS Addictive Research Ho

William Calezon's group purifies salvinorin A from bags of dried Salvia divinorum bought off the Internet." />William Calezon's group purifies salvinorin A from bags of dried Salvia divinorum bought off the Internet. For Karen Schrock, it started with a big hit off a smoking pipe filled with Salvia divinorum and a crash to the kitchen floor. From there she was off to an alien world of silhouetted figures who lived by a complex social structure. Any sense that there had ever been

William Cork's passion for startups brought him from Baxter to Nanosphere, where he's now CTO.